$SNGX Income Statement | Understand Stock

$SNGX

$0.36 +$0.01 (3.68%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Licensing revenue
Contract revenue
Grant revenue
Total revenues

Cost of revenues
Gross profit
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Gain on forgiveness of PPP loan
Foreign currency transaction loss
Interest expense
Other income (expense):
Foreign currency transaction (loss) gain
Interest income, net
Research and development incentives
CARES Act employee retention credit
Other income
Loss on extinguishment of debt
Change in fair value of convertible debt
Total other income
Net loss before income taxes
Income tax benefit
Net loss applicable to common stockholders
Basic net loss per share (in Dollars per share)
Diluted net loss per share (in Dollars per share)
Basic weighted average common shares outstanding (in Shares)
Diluted weighted average common shares outstanding (in Shares)

Comments